Related by context. All words. (Click for frequent words.) 70 riociguat 69 immune modulatory 69 Azedra 68 CGEN # 68 PROCHYMAL 68 ESBA# 67 OHR/AVR# 67 Aviptadil 67 AAGP ™ 67 immunomodulatory properties 66 Homspera 66 Xanafide 66 rBChE 66 mesenchymal stromal cells 66 adipose derived stem cell 66 MultiStem 66 TG# [003] 66 hereditary deficiency 66 adipose derived stem cells 66 GRNCM1 66 APOPTONE 66 ENMD # 66 juvenile chondrocytes 66 YONDELIS 66 Octreolin 66 tafamidis 66 fibrotic disease 66 histone deacetylase inhibitor 65 huC# DM4 65 EndoTAG TM -1 65 eprotirome 65 allogeneic cell 65 XmAb# 65 BrachySil TM 65 JAK inhibitor 65 HuMax EGFr 65 Traficet EN 65 Cethrin 65 HuMax CD4 65 deacetylase inhibitors 65 INT# [002] 65 Methylnaltrexone 65 ISTODAX 65 Vorinostat 65 Gleevec resistant 65 IL# PE#QQR 65 Trofex 65 SNT MC# 65 preclinically 65 #D#C# 65 acadesine 65 Cytolin R 65 noninfectious uveitis 65 C1 INH 65 uricase 65 CXCR7 65 thymidylate synthase TS 65 Panzem 64 adult mesenchymal stem 64 vivo potency 64 PET tracers 64 neuroprotective properties 64 kidney urologic 64 Phase 2a trial 64 plasminogen activators 64 ADAGIO study 64 butyrylcholinesterase 64 anticancer activity 64 Dacogen decitabine 64 DXL# 64 Radilex 64 Tyrima 64 #ME# 64 thrombolytic agent 64 mTOR inhibitors 64 P#X# 64 vascular disrupting agents 64 Symadex 64 TriRima 64 systemically administered 64 OncoVEX 64 stromal vascular fraction 64 ganaxolone 64 Interferon alpha 64 SARMs 64 immuno modulatory 64 investigational therapies 64 acinar cells 64 haematopoietic 64 myeloproliferative diseases 64 Acute Radiation Syndrome ARS 64 RhuDex ® 64 Alferon N 64 lomitapide 64 biomarker assay 64 Umbilical cord stem cells 64 plasma kallikrein inhibitor 64 ACV1 64 p# inhibitors 64 IRX 2 64 florbetaben 63 AZILECT ® 63 CEQ# 63 immune modulator 63 wilate ® 63 ospemifene 63 Valortim R 63 BAY #-# 63 myeloproliferative disorders 63 HQK 63 HepaGam B 63 cells MSCs 63 osteogenic 63 Bendavia 63 cytoprotective 63 ImmunoVEX HSV2 63 Anticalins ® 63 neurotrophic 63 iroxanadine 63 LEUKINE 63 Plasmin 63 mertansine 63 anticancer agent 63 orally dosed 63 therapeutic monoclonal antibody 63 HuMax CD# 63 VDAs 63 Valortim ® 63 Cytolin ® 63 ischemic tissues 63 peptide fragments 63 Amplimexon 63 injectable formulation 63 PEG SN# 63 ALN TTR# 63 MAGE A3 ASCI 63 IgG4 63 JAK2 inhibitor 63 NEUMUNE 63 Sym# 63 tezampanel 63 Abbokinase 63 GFT# 63 selective modulator 63 MYDICAR ® 63 Lisofylline 63 HuLuc# 63 OrCel 63 StemEx 63 engineered RAP peptides 63 multicenter trials 63 Removab 63 MEK inhibitors 63 LT NS# 63 RNAi therapeutic targeting 63 IMA# 63 TNFa 63 proteasome inhibitor 63 Teriparatide 63 antitumor effect 63 CYT# potent vascular disrupting 63 NovaBay Aganocide compounds 63 SERMs 63 NP2 Enkephalin 63 oral prodrug 63 TPI ASM8 63 multipotent stem cells 63 ReN# 63 immunomodulation 63 pharmacodynamic profile 63 QuadraSphere 63 mGlu2 3 63 menadione 63 novel peptide 63 UPLYSO 63 immunoregulatory 63 MAPCs 63 #beta estradiol 63 cannabinor 63 masitinib 63 Angiolix 63 selective inhibition 63 erythropoietic 63 MGd 63 Poly ICLC 63 vivo validation 63 TH# [003] 63 JAK3 63 Plicera 63 Vascugel 63 R baclofen 63 triphendiol 63 flavopiridol 63 receptor tyrosine kinase inhibitor 63 poloxamer 63 SIR Spheres 63 busulfan 62 favorable pharmacokinetic profile 62 humanized monoclonal antibodies 62 KL4 surfactant 62 ThGRF 62 vidofludimus 62 polycythemia vera PV 62 rFIXFc 62 peptide antigens 62 investigational monoclonal antibody 62 NEUGENE 62 mesenchymal stem cell 62 PCK# 62 Tß4 62 HCV protease inhibitors 62 prostanoid 62 depsipeptide 62 immune modulating 62 dexanabinol 62 DACH platinum 62 Protelos 62 PTHrP 62 myoblasts 62 Carfilzomib 62 VSELs 62 CB2 receptor 62 somatostatin analogues 62 anticancer therapies 62 Altastaph 62 Hemopurifier ® 62 malignant ascites 62 Aggrastat ® tirofiban hydrochloride 62 MP4OX 62 ATL# [002] 62 ALN TTR 62 targeted antifolate 62 OncoVEX GM CSF 62 #I TM# 62 anti Neu5Gc antibodies 62 Squalamine 62 targeted radiotherapeutic 62 AEG# 62 hypervascular tumors 62 plasma kallikrein 62 Valortim 62 proliferative disorders 62 tumorigenicity 62 ASONEP 62 docetaxel Taxotere ® 62 Factor VIIa 62 gastrointestinal stromal tumors GIST 62 TRIOLEX 62 Vidofludimus 62 ziconotide 62 vitro studies 62 PEGylated 62 chimeric monoclonal antibody 62 sd rxRNA 62 metaglidasen 62 Proxinium TM 62 anti angiogenic therapy 62 placental derived 62 Ceflatonin 62 biologic therapeutics 62 AtherOx 62 stem progenitor cells 62 miglustat 62 CCR9 antagonist 62 NV1FGF 62 sipuleucel T 62 IL 1ß 62 Mipomersen 62 cartilage regeneration 62 drug ISA# 62 lumiliximab 62 CytoFabTM 62 hESC derived 62 TLK# 62 NB S# strontium malonate 62 RECOTHROM R 62 milatuzumab 62 Phase Ib study 62 oral antiviral 62 MMP inhibitors 62 Corgentin 62 tipifarnib 62 either acutely decompensated 62 liquid fibrin sealant 62 MYCAMINE 62 splice variants 62 TLE3 62 intranasal formulation 62 pharmacological chaperone 62 prodrugs 62 anti angiogenic drugs 62 Sanvar R 62 IMP# 62 Zysolin TM 62 vorinostat 62 anticancer therapy 62 prostate epithelial cells 62 CGRP 62 DCVax ® 62 Icatibant 62 Onconase 62 AQ4N 62 Aethlon Hemopurifier R 62 CaPre TM 62 radiolabeled TM# 62 calcitonin 62 myelofibrosis polycythemia vera 62 selective adenosine 62 GGF2 62 Genz # 62 Chrysalin 62 CCR9 62 synthetic analogues 62 Afatinib 62 Anticalin ® 62 fosbretabulin 62 CA4P 62 GED aPC 62 Guanilib 62 resolvin 62 bexarotene 62 NurOwn ™ 62 Prodarsan ® 62 Gamunex C 62 interleukin IL -# 62 pexiganan 62 chemoprotective 62 arterial thrombosis 62 angiogenesis inhibitor 62 HuMax TAC 62 benfotiamine 62 ZFP TF 62 redox active 62 urocortin 2 62 SomatoKine 61 multiplex assay 61 delafloxacin 61 metastatic neuroendocrine tumors 61 REOPRO 61 synthetic retinoid 61 anti CD3 antibody 61 LHRH agonists 61 rilonacept 61 renin inhibitors 61 Ophena TM 61 chemotherapy induced neutropenia 61 Cerashield 61 BiTE 61 Nicole Onetto MD 61 TACI Ig 61 EGS# 61 Tarvacin TM 61 anti androgens 61 ProSavin 61 Bezielle 61 Myotech CSS 61 Preclinical studies suggest 61 Fabry Disease 61 epithelial tumors 61 histone deacetylase HDAC 61 Microplasmin 61 Dalbavancin 61 CBLC# 61 anti amnesic 61 ependymal cells 61 adipogenic 61 deferiprone 61 Elafin 61 DCVax R 61 GTC recombinant human 61 cellular prion protein 61 ischemia reperfusion 61 Aplidin 61 JAK inhibitors 61 elacytarabine 61 Nanobody ® 61 NOD SCID mice 61 cilengitide 61 nanopharmaceutical 61 GPx 61 Ataluren 61 BMS# 61 Ophena 61 resolvins 61 potent topoisomerase II 61 oncolytic virus 61 Protexia ® 61 Ampligen ® 61 phase IIa clinical 61 amikacin 61 Kamada AAT 61 antifibrotic 61 pDCs 61 opioid antagonists 61 antiangiogenic activity 61 IGIV 61 nonclinical studies 61 REPEL CV 61 intravenous immunoglobulin IVIg 61 Cardio Vascu Grow 61 immunomodulatory 61 EndoTAG TM 61 VitiGam 61 obatoclax 61 TB4 61 lucinactant 61 bovine thrombin 61 Mesenchymal stem cells 61 ZD# [001] 61 PXD# 61 NAGS deficiency 61 nicotinic alpha 7 61 injectable formulations 61 SEPET TM 61 MYLOTARG 61 remyelination 61 resultant PLX PLacental eXpanded 61 SUTENT ® 61 Pseudomonas aeruginosa infections 61 Ebola SNALP 61 bortezomib Velcade ® 61 synovial cells 61 ADRCs 61 BioDisc 61 ADAMTS# 61 A3 adenosine receptor 61 Viprovex TM 61 Alvesco R 61 GAMMAGARD 61 Calcitonin 61 reslizumab 61 HuCNS SC cells 61 VAPRISOL 61 ARIKACE 61 eTag assays 61 brivaracetam 61 JAK2 inhibitors 61 ATL/TV# 61 histone deacetylase HDAC inhibitor 61 AA amyloidosis 61 TELINTRA 61 mesothelial cells 61 CD# monoclonal antibody 61 receptor inhibitor 61 PDE1 61 targeting CD# 61 PlGF 61 Sudhir Agrawal D.Phil 61 interferon γ 61 recombinant factor VIIa 61 recurrent glioma 61 Enzyme Replacement Therapy 61 VEGF inhibitors 61 tumor hypoxia 61 solithromycin 61 tigecycline 61 velafermin 61 EP #R 61 Resten NG 61 Jurkat cells 61 Fibrillex TM 61 sd rxRNA compounds 61 anticancer compound 61 annexin V 61 cardioprotection 61 ImmuKnow assay 61 Personalized Immunotherapy 61 CCX# 61 Isolagen Process 61 acetonide FA 61 INTERCEPT platelets 61 CDK inhibitors 61 Pyridorin 61 Catena ® 61 small molecule activators 61 samalizumab 61 bucindolol 61 Amphinex ® 61 bortezomib Velcade 61 therapeutic monoclonal antibodies 61 novel oral anticoagulant 61 G#DT 61 Virulizin R 61 Th2 cytokines 61 ATL# [001] 61 Privigen 61 Zalypsis 61 afamelanotide 61 tranilast 61 Zemiva TM 61 PBMCs 61 CTAP# Capsules 61 cMET 61 von Willebrand factor 61 SERCA2a 61 antiproliferative effects 61 eculizumab 61 MAXY G# 61 Virulizin ® 61 ACZ# 61 Friedreich Ataxia FRDA 61 neuroregenerative 61 Litx 61 Aurexis 61 ALDH br cells 61 hematopoietic cells 61 siRNA therapeutics 61 xenograft 61 PNH patients 61 Kepivance 61 DP b# 61 imatinib resistance 61 OMNARIS HFA 61 fenretinide 61 PI3K inhibitors 61 tgAAC# 61 prostaglandin synthesis 61 EOquin TM 61 TRV# [001] 60 Aurora kinase 60 radiolabeled 60 cysteamine 60 benign prostatic hypertrophy BPH 60 Zavesca R 60 cleavable linker 60 Dacogen injection 60 proteasome inhibitors 60 macrolide antibiotics 60 BNC# 60 PRT# 60 bone morphogenetic proteins 60 Evicel 60 Neuradiab 60 monoclonal anti 60 PPARγ 60 superficial bladder cancer 60 CIMZIA ™ 60 Phase #/#a trial 60 antiangiogenic agents 60 corticosteroid dexamethasone 60 Vidaza azacitidine 60 sitaxsentan 60 Apoptone 60 cardio renal 60 SinuNase 60 tumoral 60 IPLEX 60 PEGPH# 60 colorectal adenocarcinoma 60 developing TB4 60 collagenase 60 Silodosin 60 immunomodulatory therapy 60 Phase IIb clinical trials 60 PNP inhibitor 60 BioScanIR R System 60 Cotara 60 cysteamine bitartrate 60 CYT# 60 proteomic analysis 60 Ventavis ® 60 HemoTech TM 60 selective androgen receptor modulator 60 immunotoxin 60 peptibody 60 PSMA ADC 60 posaconazole 60 Hizentra 60 pharmacokinetic interactions 60 ROTARIX 60 NS#/#A protease 60 HIF PH inhibitors 60 rxRNA 60 efalizumab 60 Bendamustine 60 BRAF inhibitors 60 metreleptin 60 Preclinical studies 60 Axiogenesis 60 Viprinex 60 thetreatment 60 uPA 60 DAVANAT 60 Spheramine 60 SPC# [001] 60 fluoroquinolone antibiotic 60 HAAH 60 GRASPA ® 60 forodesine 60 ALK inhibitors 60 adipose derived regenerative 60 HuCNS SC ® 60 thrombotic thrombocytopenic purpura TTP 60 adipose cells 60 p# biomarker 60 Levetiracetam 60 Lpathomab 60 esophageal candidiasis 60 ABLAVAR ® 60 Myocet 60 indibulin 60 MEK inhibitor RDEA# 60 Actimmune ® 60 cytotoxin 60 microRNA expression 60 anti angiogenic agents 60 multiple myeloma MM 60 potent inhibitors 60 etanercept Enbrel 60 bleomycin 60 NTDDS 60 sCD# 60 pegylated 60 mesenchymal stem cells MSCs 60 eniluracil 60 radiotherapeutic 60 compound Protectan CBLB# 60 Hemospan 60 novel VDA molecule 60 GHRH 60 ATIR 60 multipotent 60 daptomycin 60 ANAVEX #-# [001] 60 rtPA 60 LPLD 60 humanized anti 60 Dasatinib 60 Cethrin R 60 oral gallium 60 lesional 60 pharmacodynamic properties 60 AZX# 60 ZOLINZA 60 nosocomial pneumonia 60 PRTX 60 Archexin 60 PI3 kinase inhibitors 60 ProAlgaZyme 60 intracranial hemorrhage ICH 60 selective inhibitors 60 VALSTAR 60 XYNTHA 60 Losartan 60 Ganciclovir 60 antiangiogenic 60 OMP #M# 60 PROCRIT ® 60 vapreotide acetate 60 GRP# 60 defensin mimetic antibiotic 60 canakinumab 60 AeroLEF TM 60 Cardiomyocytes 60 ON #.Na 60 epigenetic therapies 60 Fc fusion protein 60 biologic pathway 60 rHuPH# enzyme 60 Orally administered 60 Cinquil 60 HepaGam B TM 60 AGHD 60 calcineurin inhibitor 60 OvaRex R 60 Omacetaxine 60 Bioral ® 60 amrubicin 60 ularitide 60 Granulocyte Colony Stimulating Factor 60 TOLAMBA 60 visilizumab 60 Nanobody 60 anticoagulant reversing agent 60 thrombolytic agents 60 Gliadel Wafer 60 RiVax 60 CB1 antagonists 60 miRview mets 60 Evoltra 60 outer membrane proteins 60 cancer immunotherapies 60 bafetinib 60 Myolimus 60 Factor IX 60 chemopreventive agent 60 Multimeric 60 antiangiogenic agent 60 effector function 60 iCell Cardiomyocytes 60 Generx 60 Darinaparsin 60 glycolipids 60 cardioprotective effects 60 Vicinium TM 60 CytoSorb 60 Cell Pouch System 60 TTR gene 60 beta lactam antibiotic 60 amifostine 60 SPRIX ® 60 PKC# 60 Azedra ™ 60 Certolizumab pegol 60 Belerofon 60 CellPort Technologies 60 CD# antibody [001] 60 Zolinza 60 renal toxicity 60 orally bioavailable 60 Beta catenin pathway 60 calcineurin inhibitors 60 poly ethylene glycol PEG 60 HIF PHI 60 Immunohistochemical analysis 60 UniBody 60 CINTREDEKIN BESUDOTOX 60 #beta HSD1 60 L asparaginase 60 pan HDAC inhibitor 60 endothelin antagonist 60 INCB# [001] 60 contractile muscle 60 PEGylated interferon 60 Ampligen R 60 Exherin TM 60 cells hESCs 60 MenSCs 60 prostate carcinoma 60 glycosylation profile 60 rFVIIIFc 60 mTOR inhibition 60 phase IIb trial 60 anti fibrotic 60 topical formulations 60 cardiac myocytes 60 Hemopurifier 60 telomerase inhibition 60 inhibiting mTOR 60 immune modulation 60 PLX PAD 60 adipiplon 60 KL4 Surfactant 60 CRLX# 60 BAL# [002] 60 Perforomist ™ Inhalation Solution 60 Bioral 60 PROMACTA 60 adipose tissue derived 60 denileukin diftitox 60 antiarrhythmic 60 Loramyc R 60 antidiabetic drug 60 Vascugel R 60 isotypes 60 OncoGel 60 Nanobodies ® 60 Fc receptor 60 preclinical efficacy 60 SGLT2 inhibitors 60 oncolytic 60 antitumoral 60 sJIA 60 BiTE antibody 60 granisetron 60 K ras mutations 60 incyclinide 60 neurotrophic factor 60 methylnaltrexone 60 BioNumerik 60 HeFH 60 ToGA 60 relapsed ALL 60 Humate P 60 Epratuzumab 60 K RAS 60 Rilonacept 60 JAK1 60 budesonide foam 60 PluriCells TM 60 Serdaxin 60 antiangiogenesis 60 small molecule thrombopoietin 60 CardioFit 60 cell lysate 60 rFVIIa 60 efaproxiral 60 transfection reagents 60 BioSilicon 60 investigational humanized monoclonal antibody 60 multicenter Phase II 60 SCIg 60 recombinant enzyme 60 Sapacitabine 60 REP# 60 endogenous ligands 60 induce apoptosis 60 Anavex #-# 60 CollaFix TM 60 therapeutic modality 60 murine antibodies 60 TYZEKA 60 MAPK pathway 60 Fodosine 60 pseudobulbar affect PBA 60 aurora kinase 60 enzyme inhibitor 60 nephrotoxicity 60 antitumor effects 59 Onalta ™ 59 TNF antagonist 59 skeletal metastases 59 KIACTA ™ 59 Dapagliflozin 59 erlotinib Tarceva ® 59 bioartificial liver device 59 Thiovir 59 immunomodulator 59 trodusquemine 59 Arikace 59 Everolimus 59 glatiramer 59 pharmacokinetic PK study 59 NIC5 59 omega interferon 59 antitumour activity 59 potent anticancer 59 liposomal formulation 59 CYP #A# 59 CoFactor 59 CYC# 59 intravenous bisphosphonates 59 Cethromycin 59 BCR ABL inhibitors 59 HepDirect prodrug 59 RLY# 59 ex vivo 59 murine model 59 hematopoietic progenitor cells 59 HER3 59 JAK2 enzyme 59 orally administered inhibitor 59 Human cl 59 Solazed TM 59 GLYX 59 pharmacogenetic testing 59 StromaCel 59 RGB # 59 interferon beta therapy 59 hERG 59 CCR1 59 5 HT2C receptor 59 DDP# 59 Phase IIB 59 PDE4 inhibitor 59 non nucleoside 59 sulindac 59 imatinib therapy 59 thymosin beta 4 59 CDK inhibitor 59 lenalidomide Revlimid R 59 VA# [002] 59 LPM TM 59 IFN β 59 T#I [002] 59 RQ PCR 59 serotonin synthesis 59 androgen receptor AR 59 immunotoxins 59 progenitor stem cells 59 Arsenic trioxide 59 alpha fetoprotein AFP 59 osteoblastic 59 INTEGRILIN 59 Gleevec Glivec 59 enzyme inhibitors 59 unspecialized cells 59 Anticalins 59 NRG1 59 BrachySil 59 humanized monoclonal 59 Degarelix 59 rHuPH# 59 trophoblast cells 59 BEMA TM Fentanyl 59 intranasal delivery 59 tolevamer 59 optimal dosing regimens 59 Soliris eculizumab 59 VEGF receptor 59 hyaluronidase enzyme 59 Zenvia Phase III 59 post menopausal osteoporosis 59 cryopreserved 59 FK# 59 ALGRX 59 cediranib 59 myocardial tissue 59 citicoline 59 ataluren 59 PROSTVAC TM 59 Src inhibitors 59 gefitinib Iressa 59 ImmuKnow 59 IL# PE 59 phase IIb clinical 59 Combidex 59 hematological cancers 59 alvespimycin 59 Pertuzumab 59 TriGrid ™ 59 myeloperoxidase 59 GAP #B# 59 trophoblasts 59 immunosuppressant drug 59 INCB# [003] 59 intravenously administered 59 IGF IR 59 alpha#beta# integrin 59 candidate TNFerade biologic 59 myocyte 59 post surgical adhesions 59 Ventavis 59 small molecule activator 59 thrombin receptor 59 PRADAXA 59 Pemetrexed 59 Vernakalant 59 alfa interferon 59 mimetics 59 direct thrombin inhibitor 59 humanized antibody 59 p# activation 59 Inhaled AAT 59 EVIZON 59 Tarvacin 59 HBV vaccine 59 Octreotide 59 luliconazole 59 Aloxi R 59 veltuzumab 59 hematologic disorders 59 topical ophthalmic 59 Factor Xa inhibitor 59 Onalta 59 cathepsins 59 ganciclovir 59 potent antiproliferative 59 teriparatide 59 diagnostic biomarker 59 chemotherapeutic drug 59 Hepatocellular Carcinoma HCC 59 ASPIRE HIGHER 59 Survivin antagonist 59 CR# vcMMAE 59 prostone 59 placenta derived 59 zileuton 59 myofibroblasts 59 allogeneic HSCT 59 QTinno TM 59 tiapamil 59 Pimavanserin 59 alefacept 59 Muraglitazar 59 E. faecalis 59 bioscavenger 59 inhibit metastasis 59 Crofelemer 59 Thrombin 59 multipotent cells 59 hepatic toxicity 59 partial agonist 59 CA9 SCAN 59 vWF 59 IAP inhibitor 59 pomalidomide 59 immunosuppressive regimens 59 fumagillin nanoparticles 59 proteoglycan 59 chronic hemolysis 59 pharmacodynamic parameters 59 olaparib 59 TEMODAL 59 TYSABRI natalizumab 59 HIF 1a 59 HoFH 59 R#/MEM # 59 Interferon beta 59 nanomedicines 59 adenoviral 59 microglial activation 59 tubulin inhibitor 59 TREANDA 59 antitumor efficacy 59 cidofovir 59 OXi# 59 nerve regrowth 59 rhITF